KeyBank National Association’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

KeyBank National Association’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-12,835	Closed	-$121K	–	1118
2023 Q3	$121K	Sell	12,835 -6,521	-34%	-$78.5K	﹤0.01%	1000
2023 Q2	$270K	Hold	19,356	–	–	﹤0.01%	917
2023 Q1	$363K	Hold	19,356	–	–	﹤0.01%	825
2022 Q4	$267K	Hold	19,356	–	–	﹤0.01%	907
2022 Q3	$370K	Buy	19,356 +1,350	+7%	+$24.6K	﹤0.01%	765
2022 Q2	$275K	Buy	+18,006	New	+$266K	﹤0.01%	907

Other funds holding CDMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

KeyBank National Association's CDMO Position: Q4 2023 in Review

KeyBank National Association sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2023, closing a stake of 12,835 shares — an estimated $121K sold.

KeyBank National Association first reported a position in CDMO in Q2 2022 and held it in 6 quarters. The position peaked at $370K in Q3 2022. 175 funds tracked by Wall St. Rank hold CDMO as of Q4 2023.

KeyBank National Association reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
KeyBank National Association sold 12,835 Avid Bioservices, Inc. Common Stock shares in Q4 2023, an estimated $121K.
KeyBank National Association first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2022 and held it in 6 quarters.
KeyBank National Association's Avid Bioservices, Inc. Common Stock position peaked at $370K in Q3 2022.
175 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2023.

Based on KeyBank National Association's 13F filing for Q4 2023, filed 13 Feb 2024.